Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.750
+0.015 (2.03%)
May 3, 2024, 10:53 AM EDT - Market closed
Pharma-Bio Serv Revenue
Pharma-Bio Serv had revenue of $15.12M in the twelve months ending January 31, 2024, down -18.80% year-over-year. Revenue in the quarter ending January 31, 2024 was $2.38M, a -43.84% decrease year-over-year. In the fiscal year ending October 31, 2023, Pharma-Bio Serv had annual revenue of $16.98M, a decrease of -12.48%.
Revenue (ttm)
$15.12M
Revenue Growth
-18.80%
P/S Ratio
1.14
Revenue / Employee
$151,187
Employees
100
Market Cap
17.22M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2023 | 16.98M | -2.42M | -12.48% |
Oct 31, 2022 | 19.40M | -716.45K | -3.56% |
Oct 31, 2021 | 20.12M | -1.45M | -6.72% |
Oct 31, 2020 | 21.56M | 2.06M | 10.55% |
Oct 31, 2019 | 19.51M | 1.71M | 9.61% |
Oct 31, 2018 | 17.80M | 2.22M | 14.24% |
Oct 31, 2017 | 15.58M | -3.96M | -20.26% |
Oct 31, 2016 | 19.54M | -3.85M | -16.46% |
Oct 31, 2015 | 23.38M | -4.17M | -15.13% |
Oct 31, 2014 | 27.56M | -5.51M | -16.66% |
Oct 31, 2013 | 33.06M | 3.83M | 13.12% |
Oct 31, 2012 | 29.23M | 9.29M | 46.63% |
Oct 31, 2011 | 19.93M | 8.59M | 75.68% |
Oct 31, 2010 | 11.35M | -132.63K | -1.16% |
Oct 31, 2009 | 11.48M | -3.72M | -24.46% |
Oct 31, 2008 | 15.20M | -1.01M | -6.22% |
Oct 31, 2007 | 16.20M | 1.98M | 13.88% |
Oct 31, 2006 | 14.23M | 14.22M | 142,198.31% |
Jun 30, 2005 | 10.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
PBSV News
- 6 weeks ago - Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024 - Accesswire
- 3 months ago - Pharma-Bio Serv Announces Full Year Results - Accesswire
- 4 months ago - Pharma-Bio Serv Announces Special Dividend - Accesswire
- 8 months ago - Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023 - Accesswire
- 11 months ago - Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023 - Accesswire
- 1 year ago - Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023 - Accesswire
- 1 year ago - Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services - Accesswire
- 1 year ago - Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2022 - Accesswire